Loading... Please wait... Loading... Please wait...
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to host analyst and investor education webcast with clinical and brain imaging experts on June 25, 2024....
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These are Vita Coco Company (COCO), AMC Entertainment (AMC), Hyperfine (HYPR), Aptevo Therapeutics (APVO) and CLEAR Se...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. continues global expansion by entering into distribution partnership with Radiosurgery Global, Ltd. to bring Swoop® system to India....
If you have some spare change jingling in your pocket, it might be worth considering investing that money in penny stocks with good upside potential. The penny stocks on this list are each worth l...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the Jefferies Global Healthcare Conference....
LAS VEGAS--(BUSINESS WIRE)--The 2024 ASNR Annual Meeting had a strong focus on Alzheimer's disease care and growing excitement about ultra-low-field MRI....
Hyperfine, Inc. (NASDAQ:HYPR ) Q1 2024 Earnings Conference Call May 13, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Investor Relations Maria Sainz - President and Chief Execut...
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.17 per share a year ago....
GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magn...
